Delivery Order SPE2DB22D2211-SPE2DB24FPDS1

Award Date 8/15/24
Potential Completion Date 8/16/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,282.61 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Ketorolac 10mg tablets. The contract has an ultimate completion date of July 30, 2025 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,102,721 units of the medication Ketorolac 10 mg tablet. The contract has a firm fixed price of $4,058.39 and a performance period ending on May 2, 2025. The contract is not set aside and was awarded on May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation (a subsidiary of Amerisourcebergen Corporation) as a firm fixed price delivery order. The award, valued at $2,655.19, is for the provision of 4,557,130,755 units of the pharmaceutical drug Ketorolac 10 mg Tablet. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was awarded solely to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,020.12 award is for the supply of 4,565,063 units of the pain medication Ketorolac 10 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 10 mg tablets. The $1,926.64 firm-fixed-price contract has a completion date of July 18, 2024. AmerisourceBergen, as the prime contractor, will provide these prescription medications to support military treatment facilities and federal healthcare programs. The contract is not designated as a set-aside. AmerisourceBergen holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of 4565456760 ketorolac 10 milligram tablets in 100-count bottles, with a firm fixed price of $1,302.62 and a period of performance through August 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,454.22 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. This contract is for the supply of 4,565,751,220 units of the pharmaceutical product Ketorolac 60 mg/2 ml vial. The contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been awarded this delivery order under a...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,502,885 units of Ketorolac 60 mg/2 ml vials. The total ceiling value of the contract is $1,591.70 with a completion date of June 11, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,082,529 units of the pharmaceutical product Ketorolac 30mg/ml 25s. The $2,600.25 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, on July 8, 2024 with a completion date of July 9, 2024. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,503,961 units of Ketorolac 60 mg/2 ml vial, a pharmaceutical product. The award has a ceiling value of $2,930.75 and a completion date of August 20, 2024. This contract is not set-aside. AmerisourceBergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPDS1
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,565,471,414 units of the prescription medication Ketorolac 10 mg Tablet, with a total ceiling value of $1,464.95. The contract has a firm-fixed price pricing type and an ultimate completion date of August 16, 2024. Amerisourcebergen is one of the primary suppliers of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals, through various Indefinite Delivery Contracts (IDCs) with the DLA and other agencies. This contract award is not set aside and is part of Amerisourcebergen's broader federal contracting portfolio, which includes multimillion-dollar IDCs to provide a comprehensive range of essential medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/14/24, 9:14 AM